Loading...
XHEL
ORIOLA
Market cap213mUSD
Apr 04, Last price  
1.02EUR
Name

Oriola Oyj

Chart & Performance

D1W1MN
XHEL:ORIOLA chart
P/E
—
P/S
0.11
EPS
—
Div Yield, %
6.86%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-0.49%
Revenues
1.68b
+12.44%
662,700,0001,377,300,0001,580,800,0001,713,100,0001,929,400,0002,146,000,0002,474,400,0002,598,500,0001,612,300,0001,626,300,0001,642,100,0001,527,700,0001,552,200,0001,721,300,0001,800,800,0001,882,400,0001,515,500,0001,493,800,0001,679,700,000
Net income
-20m
L-2.90%
9,600,00023,300,00027,500,00048,600,000102,100,000-24,100,00017,200,0005,800,000-212,300,00044,600,00042,800,00026,300,00012,700,0008,000,00011,300,00011,300,0004,800,000-20,700,000-20,100,000
CFO
39m
+303.13%
46,100,00039,000,000-18,100,000100,900,00088,700,00028,100,00046,100,00029,800,000-10,800,00085,600,00040,100,00023,700,000102,800,00084,400,00058,300,00040,000,00077,900,0009,600,00038,700,000
Dividend
Mar 20, 20240.07 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops. In addition, the company offers pharmaceutical staffing and dose dispensing services for public and private healthcare operators, pharmacies, groceries, veterinarians, and retailers. As of December 31, 2021, it operated 319 pharmacies in Sweden, as well as operates online pharmacies. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. Oriola Oyj is headquartered in Espoo, Finland.
URL
https://www.oriola.com/
IPO date
Jul 03, 2006
Employees
797
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT